Interestingly, an in vivo study showed that IL6 could drive engraftment of xenografts derived from an oestrogen-dependent BC cell line in the absence of hormonal supplementation and this could be blocked using an IL6 inhibitor [118]. This evidence concerns the gene IL6 and breast cancer.